Continued Use of Effective Contraception After Use of Emergency Contraception

Contraception Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02078414
• Other study ID #: RFSU1
• Status: Completed
• Start date: March 2014
• Est. completion date: May 2015

Study information

• Verified date: November 2023
• Source: Karolinska Institutet
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Women using an emergency contraceptive method must use back up protection for 1-2 weeks depending on method. The Copper-IUD is the most effective emergency contraceptive method. The investigators wish to explore if women choosing the Cooper IUD have a higher frequency of use of an effective contraceptive method 3 months and 6 months after the use of an emergency contraceptive method than women who choose to use the emergency contraceptive pill EllaOne (ulipristal acetate).

Recruitment information / eligibility

• Status: Completed
• Enrollment: 7
• Est. completion date: May 2015
• Est. primary completion date: February 2015
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 18 Years to 45 Years

Eligibility

Inclusion Criteria:

• women over 18 years

• eligible for all emergency contraception

Exclusion Criteria:

• previous conisation

• known stenosis of the cervix

• signs of ongoing genital infection

• known uterine anomaly

• Known bleeding disorder

Related Conditions & MeSH terms

• Contraception
• Emergencies
• Emergency Contraception
• Reproductive Health

Locations

Country	Name	City	State
Sweden	RFSU clinic	Stockholm

Sponsors (1)

Lead Sponsor	Collaborator
Karolinska Institutet

Country where clinical trial is conducted

Sweden, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Use of an effective contraceptive method	Use of pill, patch, ring, IUD, IUS, or injection 6 months after use of emergency contraceptive method	6 months after emergency contraceptive use